» Articles » PMID: 21170564

Value and Utility of Disease-specific and Generic Instruments for Assessing Disability in Patients with Migraine, and Their Relationships with Health-related Quality of Life

Overview
Journal Neurol Sci
Specialty Neurology
Date 2010 Dec 21
PMID 21170564
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this paper is to explore the relationships between health-related quality of life (HRQoL), assessed with the Short Form-36 (SF-36), and disability in adult migraineurs using both disease-specific and generic tools, the WHO Disability Assessment Schedule II (WHO-DAS II) and with the Migraine Disability Assessment questionnaire (MIDAS). Significant differences were observed between patients with minimal/mild and moderate/severe MIDAS disability grades for Role Physical, Bodily Pain, General Health, Vitality, Social Functioning and Physical Composite Score of the SF-36; in the WHO-DAS II for household activities, participation in society and for summary score. WHO-DAS II and MIDAS provide complementary information on the intensity and the frequency of problems in performing daily activities, and could be used jointly. Our findings indicate that these issues are relevant for patients' health status and should be taken into account in future research on migraine as important secondary outcomes of treatment interventions.

Citing Articles

Comparison of Craniosacral Therapy and Myofascial Relaxation Techniques in People with Migraine Headache: A Randomized Controlled Study.

Araci A, Ozsimsek A, Yulug B, Karacay E J Chiropr Med. 2024; 23(3):114-126.

PMID: 39670206 PMC: 11632789. DOI: 10.1016/j.jcm.2024.08.010.


Health-related quality of life among women and men living with migraine: a Canada-wide cross-sectional study.

Tam A, Naik H, Trenaman L, Lynd L, Zhang W J Headache Pain. 2024; 25(1):170.

PMID: 39379822 PMC: 11462961. DOI: 10.1186/s10194-024-01882-4.


Two randomized migraine studies of galcanezumab: Effects on patient functioning and disability.

Ford J, Ayer D, Zhang Q, Carter J, Leroux E, Skljarevski V Neurology. 2019; 93(5):e508-e517.

PMID: 31270220 PMC: 6693431. DOI: 10.1212/WNL.0000000000007856.


Migraine-Specific Quality of Life Questionnaire Chinese version 2.1 (MSQv2.1-C): psychometric evaluation in patients with migraine.

Chang H, Jensen M, Yang C, Lai Y Health Qual Life Outcomes. 2019; 17(1):108.

PMID: 31234894 PMC: 6591995. DOI: 10.1186/s12955-019-1169-y.


Beta-blockers for the prevention of headache in adults, a systematic review and meta-analysis.

Jackson J, Kuriyama A, Kuwatsuka Y, Nickoloff S, Storch D, Jackson W PLoS One. 2019; 14(3):e0212785.

PMID: 30893319 PMC: 6426199. DOI: 10.1371/journal.pone.0212785.


References
1.
Berg J, Stovner L . Cost of migraine and other headaches in Europe. Eur J Neurol. 2005; 12 Suppl 1:59-62. DOI: 10.1111/j.1468-1331.2005.01192.x. View

2.
Massetto N, Gambini C, Bernardoni P, Ferrante E, Lovati C, Moschiano F . Underdiagnosis of primary headaches: results of a survey on patients attending headache centres. Neurol Sci. 2009; 30 Suppl 1:S129-31. DOI: 10.1007/s10072-009-0068-0. View

3.
Ware Jr J . SF-36 health survey update. Spine (Phila Pa 1976). 2000; 25(24):3130-9. DOI: 10.1097/00007632-200012150-00008. View

4.
Bussone G, Usai S, Grazzi L, Rigamonti A, Solari A, DAmico D . Disability and quality of life in different primary headaches: results from Italian studies. Neurol Sci. 2004; 25 Suppl 3:S105-7. DOI: 10.1007/s10072-004-0263-y. View

5.
Stovner L, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A . The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007; 27(3):193-210. DOI: 10.1111/j.1468-2982.2007.01288.x. View